News from Holden
Is CAR T-cell therapy the future of cancer treatment?
University of Iowa Holden Comprehensive Car
Rare cancer care
Treating two girls with the same rare cancer is more than a coincidence for UI adult and pediatric specialists.
Bladder cancer breakthrough
With the conventional first-line drug for early-stage bladder cancer in severe shortage, new therapies developed at Iowa are poised to lead a new wave of care.
Clinical trial results may change practice for treating endometrial cancer
Adding immunotherapy improves outcomes f
Weiner to step down as director of Holden Comprehensive Cancer Center March 31; Henry to serve as interim director
George Weiner, MD, director of University of Iowa Holden Comprehensive Cancer Center, will step down from the leaders
Caris’ Precision Oncology Alliance Welcomes University of Iowa Holden Comprehensive Cancer Center
Holden Cancer Center joins Caris’ extensive network of leading cancer institutions committed to utilizing clinical
Holden Comprehensive Cancer Center among nation’s top cancer organizations to issue joint call to action for increased lung cancer screening
University of Iowa’s Holden Comprehensive Cancer Center has partnered with more than 50 cancer organizations to issue a call to action urging individuals, providers and insurers to increase access to and utilization of low-dose computed tomography (CT) scans for those at high risk for lung cancer.
Unique bone cancer treatment is customized to each patient’s anatomy
The treatment uses 3D technology to precisely map tumor removal and develop prosthetics that are unique to each patient’s anatomy. It’s helping patients get back to their active lifestyles sooner.